Advancing the science of cancer in Latinos.

A Amelie G. Ramirez R Rebecca Jones M Matthew P. Banegas (CHEER, UCSD Health, La Jolla, CA) M M. Constanza Camargo (Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD) G Gerardo Colon-Otero (Mayo Clinic Florida, Jacksonville, FL) C Cliff Despres (UT Health San Antonio, San Antonio, TX) L Laura Fejerman F Filipa Lynce (Dana–Farber Cancer Institute, Harvard Medical School, Boston) M Martin Mendoza (Centers for Medicare and Medicaid Services, Baltimore, MD) P Patricia Moreno A Alejandro Recio-Boiles (University of Arizona College of Medicine, Department of Hematology & Oncology, Tucson, AZ) B Barbara Segarra-Vazquez (SWOG Patient Advocate, San Juan, PR, Puerto Rico) S Sandi Stanford (Alamo Breast Cancer Foundation, San Antonio, TX) M Mariana C. Stern K Katherine Y Tossas (Virginia Commonwealth University, Richmond, VA) N Nicolette Orozco (UT Health San Antonio, San Antonio, TX) E Edward Trapido

Abstract

e13808 Background: Cancer is a leading cause of death for Latinos. They experience higher rates than their white peers of preventable, infectious-agent-causing-cancers, such as stomach & liver cancer. Latina women have experienced a 1% rise in cancer cases since 2011 & Latino children & adolescents experience higher rates of leukemia than any other racial/ethnic group. Latinos face disparities in access to healthcare, cancer screening & treatment, medical representation & experience lower rates of survival due to late-stage cancer diagnosis. Methods: To combat these inequities & identify equitable interventions for Latino health, the Institute of Health Promotion Research & the Mays Cancer Center established the Advancing the Science of Cancer in Latinos (ASCL) Conference. The fourth ASCL Conference convened in San Antonio, TX from February 21-23, 2024. The conference objectives were 1) Examine the intersection of health equity & biological underpinnings in cancer control, prevention, and treatment 2) Foster collaborative initiatives among attendees aimed at addressing cancer-related health disparities within the Latino community. The conference hosted 286 participants (speakers, researchers, physicians, healthcare professionals, patient advocates & students). It comprised of 23 sessions (3 keynotes, 6 plenaries, 6 breakouts, 3 general sessions, 1 special session, 1 lunch panel session) featuring insights from 51 speakers, a poster session highlighting 80 research abstracts & a rapid-fire session tailored for early-career investigators. Sessions focused on multiple topics relevant to Latino cancer research, clinical trials, survivorship, patient advocacy, climate change impacts on cancer, precision medicine, health policy & social determinants of health. Results: A post-conference survey from a cohort of 48 respondents underscored high levels of satisfaction, with 90% expressing contentment regarding the conference experience. Nearly all respondents (98%) rated the relevance of conference content to Latino cancer science as excellent, with 93% regarding the conference as an exceptional platform for information exchange. Impressions regarding session quality were positive, with 90% of respondents indicating a high level of satisfaction, & all survey respondents acknowledging the objectivity, balance & absence of commercial bias in the session content. Conclusions: Results showed that the resounding positivity in attendee feedback reflects the conference's success in fostering meaningful engagement among attendees. The ASCL conference facilitated an understanding of cultural nuances and barriers specific to the Latino community, stimulating collaborative efforts aimed at enhancing Latino health outcomes. Overall, this analysis affirms the conference's success in achieving its stipulated objectives and underscores the need of having consistently coordinated research endeavors to reduce Latino health disparities.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (17)

A

Amelie G. Ramirez

R

Rebecca Jones

M

Matthew P. Banegas

CHEER, UCSD Health, La Jolla, CA

M

M. Constanza Camargo

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD

G

Gerardo Colon-Otero

Mayo Clinic Florida, Jacksonville, FL

C

Cliff Despres

UT Health San Antonio, San Antonio, TX

L

Laura Fejerman

F

Filipa Lynce

Dana–Farber Cancer Institute, Harvard Medical School, Boston

M

Martin Mendoza

Centers for Medicare and Medicaid Services, Baltimore, MD

P

Patricia Moreno

A

Alejandro Recio-Boiles

University of Arizona College of Medicine, Department of Hematology & Oncology, Tucson, AZ

B

Barbara Segarra-Vazquez

SWOG Patient Advocate, San Juan, PR, Puerto Rico

S

Sandi Stanford

Alamo Breast Cancer Foundation, San Antonio, TX

M

Mariana C. Stern

K

Katherine Y Tossas

Virginia Commonwealth University, Richmond, VA

N

Nicolette Orozco

UT Health San Antonio, San Antonio, TX

E

Edward Trapido